These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21488475)

  • 21. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Navrongo Community Health and Family Planning Project.
    Binka FN; Nazzar A; Phillips JF
    Stud Fam Plann; 1995; 26(3):121-39. PubMed ID: 7570763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equipoise and the ethics of clinical research.
    Freedman B
    N Engl J Med; 1987 Jul; 317(3):141-5. PubMed ID: 3600702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The duty to exclude: excluding people at undue risk from research.
    Weijer C; Fuks A
    Clin Invest Med; 1994 Apr; 17(2):115-22. PubMed ID: 8004847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The case for an Australian national neurosciences trial network.
    Vajda FJ
    J Clin Neurosci; 2006 Feb; 13(2):168-9. PubMed ID: 16503484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External quality assurance in Malaysia.
    Nawawi H; Lim HH; Zakiah I
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():39-45. PubMed ID: 10926257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigator-led clinical research consortia: the Canadian Critical Care Trials Group.
    Marshall JC; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S165-72. PubMed ID: 19104219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical considerations in planning and conducting clinical trials with investigational or marketed drugs.
    Spilker B
    Clin Neuropharmacol; 1983; 6(4):325-47. PubMed ID: 6661731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinician as investigator: participating in clinical trials in the practice setting.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):2672-9. PubMed ID: 15173050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The PAL+ program, an incentive concerted action about malaria and associated infectious diseases, for developing countries].
    Agid F
    J Soc Biol; 2004; 198(3):207-11. PubMed ID: 15662937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trials in vulnerable populations.
    Cook D; Moore-Cox A; Xavier D; Lauzier F; Roberts I
    Clin Trials; 2008; 5(1):61-9. PubMed ID: 18283082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conduct of clinical trials in developing countries: a perspective.
    Devasenapathy N; Singh K; Prabhakaran D
    Curr Opin Cardiol; 2009 Jul; 24(4):295-300. PubMed ID: 19444095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Status and Challenges of Cancer Clinical Trials in Korea.
    Shim BY; Park SH; Lee S; Kim JS; Lee KE; Kang YK; Ahn MJ
    Cancer Res Treat; 2016 Jan; 48(1):20-7. PubMed ID: 25761486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toward a success of investigator initiated study].
    Harigai M
    Arerugi; 2011 Nov; 60(11):1527-31. PubMed ID: 22270127
    [No Abstract]   [Full Text] [Related]  

  • 37. [Standard Cancer Therapy Are Established by the Investigator-Initiated Post-Marketing Clinical Trials, Not by the Indication-Directed Clinical Trials].
    Shimada Y
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):473-5. PubMed ID: 27220797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Challenges of Investigator-initiated Clinical Trials to Support 
the New Drug Development].
    Bai H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):511-516. PubMed ID: 35899450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Support Team for Investigator-Initiated Clinical Research].
    Fujii H
    Brain Nerve; 2017 Jul; 69(7):733-741. PubMed ID: 28739986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials.
    Mudaranthakam DP; Phadnis MA; Krebill R; Clark L; Wick JA; Thompson J; Keighley J; Gajewski BJ; Koestler DC; Mayo MS
    Contemp Clin Trials Commun; 2020 Jun; 18():100579. PubMed ID: 32510004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.